ArticleAnalytical chemistry2025
Adaptive Modeling of Tandem Mass Spectrometry Data: Creation of the METLIN 960K MRM Database.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Untargeted Multiple Reaction Monitoring.Analytical chemistry · 2026Article
- AI redefine untargeted metabolomics: estimating chemical amounts for a Human Exposome Project.Frontiers in public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Multiple Reaction Monitoring (MRM) remains the gold standard for quantitative mass spectrometry but continues to be constrained by the limited availability of high-quality transitions and collision energy (CE) values for many biologically and chemically relevant molecules. Here, we present the METLIN 960K MRM library, a 960,000-compound transition resource derived entirely from empirically acquired MS/MS data. MRM transitions were generated in both positive and negative ionization modes using an empirical spline-based pipeline refined by AI BioSync, an XCMS enhancement that provides a framework of AI and machine-learning tools designed to decipher spectral data for biological and analytical relevance. Central to this approach is spline fitting of CE-dependent intensity profiles from experimental MS/MS data collected at four discrete energies (0, 10, 20, and 40 eV), enabling continuous CE modeling and precise prediction of optimal fragmentation conditions. Supervised learning models were used within AI BioSync to refine spline fitting across diverse chemical classes, improving reproducibility and predictive accuracy. Validation across more than 100 authentic compounds, including rare metabolites and diverse small molecules, demonstrated robust detection down to 1 nM, confirming both sensitivity and scalability. This framework also holds immediate applicability for preclinical drug development studies, where authentic metabolite and impurity standards are often unavailable. Unlike prior methods reliant on
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.